Diabetes Mellitus Services
6 services found
by:MtoZ Biolabs based in, MASSACHUSETTS (USA)
Diabetes is marked by hyperglycemia, resulting from defects in insulin secretion and action, which disturbs the metabolism of carbohydrates, fats, and proteins. Type 1 Diabetes (T1D) is an autoimmune disease where T cells mediate inflammation and specifically damage pancreatic β ...
by:Scoliologic.ru, LLC based inSaint Petersburg, RUSSIA
The main reason for the manufacture of prostheses are injuries. Their share among all pathologies about 70%. Other causes are obliterating diseases of lower extremities, diabetes mellitus and ...
Manufactured by:Alfa Chemistry based inNY, NEW YORK (USA)
Epalrestat is a carboxylic acid derivative and a noncompetitive and reversible aldose reductase inhibitor used for the treatment of diabetic neuropathy, which is one of the most common long-term complications in patients with diabetes mellitus. Alfa Chemistry offers high quality epalrestat to customers which meets the CP & JP standards. Please ...
Manufactured by:Cloud-Clone Corp. based inKaty, TEXAS (USA)
These include antisense and antigene drugs, antibody-based drugs, cytokines and protein drugs, mass screening of chemical drugs in vitro and vivo as well. It applies to the study of preclinical validity at home and ...
Manufactured by:Nexelis based inSeattle, WASHINGTON (USA)
Testing Services to Support Your Preclinical and Phase I-IV Drug Programs. Nexelis, a Q² Solutions Company, provides biomarker assay services in inflammation and immunology, oncology, organ injury (renal), nutritional health, cardiovascular, metabolic (NASH/NAFLD) and infectious diseases. Our scientists approach your projects with flexible and creative solutions, developing fit-for-purpose ...
by:MtoZ Biolabs based in, MASSACHUSETTS (USA)
Biosimilars are biological products that are highly similar to an approved original biological drug (reference or brand drug) without any clinically meaningful differences in quality, safety, or efficacy compared to those approved. Biosimilars typically enter the market after the patent protection period of the original drug has expired, providing a more cost-effective treatment ...